Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBN for Treatment of Amyotrophic Lateral Sclerosis
ChiCTR2000039689Phase 2Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Oct 2020
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tetramethylpyrazine nitrone in amyotrophic lateral sclerosis (ALS) (3 arms), sponsored by Peking University Third Hospital. Primary endpoint: ALSFRS-R score. Started Oct 2020; status: recruiting.
02
Drugs
tetramethylpyrazine nitrone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on ChiCTR2000039689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039689.